Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Ex-Fundana analyst to launch systematic tail risk hedge fund with responsible bias by January

Monday, September 16, 2013

amb
Bruno Guillemin
Benedicte Gravrand, Opalesque Geneva for New Managers:

Bruno Guillemin, former senior hedge fund analyst at a fund of hedge funds house in Geneva, is preparing the launch of his own tail risk hedge fund.

The Leprin Tail Risk Green Fund’ strategy is long volatility using CTA-like models to get rare signals of pending market crashes. The fund buys short term options when a signal is generated, otherwise it is in cash. Those signals will also be given to clients.

It is high risk / high return strategy which provides strong alpha generation and negative correlation to a portfolio of risky assets.

The fund is a socially responsible fund as it is expected to direct 30 to 50% of its performance fees to a new Foundation, which will provide start-up capital to small entrepreneurs in the Eurozone.

Following up tail risk hedge funds "We first invested in 2008 in a long-volatility product, but it did not last the year. But I became very interested in tail risk investing and from then on, while working at Fundana, I followed up tail risk hedge funds." Bruno Guillemin told Opalesque.

While at Fundana, Guillemin was a generalist senior hedge fund analyst, involved in sourcing new hedge fund ideas and responsible for the quantitative risk management of the firm’s fund of hedge funds portfolios.

Most of the tail risk hedge funds that he followed were launched after 2008. They......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner